Heparin cofactor ii

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Selective thrombin inhibitor. The heparin cofactor II does not act on AT-III. Its effect is enhanced by heparin and forms a complex with thrombin. The molecular weight is 65 kD.

The synthesis of the heparin cofactor II takes place in the liver, the plasma concentration is 9mg/l.

The half-life is 2.5 days. A lack of heparin cofactor II is associated with an increased risk of thrombosis.

LiteratureThis section has been translated automatically.

  1. HA Neumann (2014) The coagulation system. ABW-Wissenschaftsverlag GmbH Berlin p. 96.

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer